NCT02705859 2025-01-09
Panther
Cancer Trials Ireland
Phase 1 Completed
Clinical Trials
4 trialsNCT02649686 2023-08-04
Durvalumab in Patients With HER-2 Positive Metastatic Breast Cancer Receiving Trastuzumab
Canadian Cancer Trials Group
Phase 1 Completed
NCT01423123 2014-07-08
Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer
NSABP Foundation Inc
Phase 1 Completed
NCT00068757 2012-09-12
Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Completed